Answers are grounded in this paper and cite their sources.
Case report reveals unique molecular alterations in nodal-positive ChRCC, suggesting aggressive characteristics.
Chromophobe renal cell carcinoma (ChRCC) is a renal malignancy typically associated with indolent behavior, with nodal involvement being rare. We report a 78-year-old African American male with incidentally discovered node-positive (pN+) ChRCC with sarcomatoid differentiation who developed spinal metastases despite adjuvant pembrolizumab. Histopathologic evaluation demonstrated distinct plant-like cell membranes, while genomic profiling revealed CDK4 amplification and MTAP and CDKN2A alterations associated with aggressive tumor biology. Notably, the tumor also exhibited additional unique molecular alterations that have not been previously reported in the literature.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: